Answers are grounded in this paper and cite their sources.
Objective To construct a nomogram based on factors associated with thyroid nodules in patients with type 2 diabetes mellitus (T2DM). Methods A total of 320 T2DM patients treated at our hospital from February 2023 to January 2025 were retrospectively included and randomly divided into a training set (70%, n = 224) and an internal validation set (30%, n = 96). The training set was further classified into non-thyroid nodule ( n = 159) and thyroid nodule ( n = 65) groups based on baseline thyroid ultrasonography. Lasso and logistic regression analyses were used to identify factors associated with thyroid nodule detection and construct the nomogram. Model performance was evaluated using ROC curves, calibration curves, the Hosmer–Lemeshow test, and decision curve analysis. Results Baseline clinical characteristics did not differ significantly between the training and validation sets ( P > 0.05). In the training set, older age (OR = 1.122, 95% CI: 1.068–1.178), female sex (OR = 4.059, 95% CI: 1.603–10.276), higher BMI (OR = 1.520, 95% CI: 1.238–1.866), hypertension (OR = 5.283, 95% CI: 2.045–13.646), higher HbA1c (OR = 2.197, 95% CI: 1.292–3.734), and higher IGF-1 (OR = 1.019, 95% CI: 1.006–1.032) were independently associated with thyroid nodule detection ( P < 0.05). The model showed good calibration, with Hosmer–Lemeshow test P values of 0.382 and 0.349 in the training and validation sets, respectively. The AUCs were 0.934 (95% CI: 0.899–0.969) and 0.925 (95% CI: 0.886–0.964), with sensitivities of 84.62% and 80.77% and specificities of 86.16% and 87.14%, respectively. Conclusion The nomogram may help identify T2DM patients with a higher probability of thyroid nodules; however, external validation is required before clinical application.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: